Summary
The Broad Institute Inc (Broad Institute), a subsidiary of The Broad Foundation, is a non-profit research organization that meets critical challenges in biology and medicine. The institute transforms medicine by utilizing systematic approaches in biological sciences, to speed up the understanding and treatment of disease. It focuses on the discovery, development and optimization of technological tools that are needed to obtain and analyze massive amounts of genome-related data. The institute’s projects aim to assemble a complete picture of the molecular components of life; define the biological circuits that underlie cellular responses; uncover the molecular basis of major inherited diseases; unearth all the mutations that underlie different cancer types; discover the molecular basis of major infectious diseases, and transform the process of therapeutic discovery and development. Broad Institute is headquartered in Cambridge, Massachusetts, the US.
The Broad Institute Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
'
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
The Broad Institute Inc, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 6
The Broad Institute Inc, Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 7
The Broad Institute Inc, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 8
The Broad Institute Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 9
The Broad Institute Inc, Medical Devices Deals, 2010 to YTD 2016 10
The Broad Institute Inc, Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 11
The Broad Institute Inc, Pharmaceuticals & Healthcare, Deal Details 13
Partnerships 13
Cohen Veterans Bioscience Partners with Stanley Center for Psychiatric Research 13
Broad Institute Genomic Services Partners with Takeda Pharma 14
Beryllium Enters into Development Agreement with Broad Institute for MCL-1 platform 15
Bayer HealthCare Expands Co-Development Agreement with Broad Institute for Cardiovascular Therapies 16
AstraZeneca Enters into Research Agreement with Broad Institute and Whitehead Institute 17
Eisai Enters into Research Agreement with Broad Institute 19
Tetra Discovery Enters Into Co-Development Agreement With Stanley Center For Schizophrenia Therapeutics 20
EMD Serono Enters Into Research Agreement With Pfizer And Broad Institute 21
Massachusetts General Hospital Enters Into Collaboration Agreement With Broad Institute And Amgen For Drug Discovery 23
Eisai Enters Into Co-Development Agreement With Broad Institute For Neglected Tropical Diseases And Tuberculosis 25
Bayer HealthCare Pharma And Broad Institute Enter Into Agreement To Develop Cancer Therapy 26
AstraZeneca And Broad Institute Partner To Advance Discovery Of Antibacterial And Antiviral Agents 28
Licensing Agreements 29
Albany Molecular Research Enters into Licensing Agreement with Broad Institute 29
Evotec Enters into Licensing Agreement with Broad Institute 30
Transposagen Biopharma Enters into Licensing Agreement with Broad Institute 31
Neon Therapeutics Enters into Licensing Agreement with Broad Institute, Dana-Farber Cancer Institute and Massachusetts General Hospital 32
Sigma Life Science Enters into Licensing Agreement with Broad Institute for Crispr Gene Engineering System 34
GE Healthcare Life Sciences Enters into Licensing Agreement with Broad Institute for Crispr Gene Engineering System 35
Editas Medicine Enters into Licensing Agreement with Broad Institute of Harvard and MIT, and Harvard University 36
Clontech Lab Enters into Licensing Agreement with Broad Institute for Crispr Gene Editing System 38
Sage Labs Enters into Licensing Agreement with Broad Institute for Crispr Gene Editing System 39
Applied Stemcell Enters into licensing Agreement with Broad Institute 40
Horizon Discovery Enters into Licensing Agreement with Broad Institute for Crispr Gene Editing System 41
ChemAxon Enters Into Licensing Agreement With Broad Institute Of Harvard And MIT 42
The Broad Institute Inc - Key Competitors 43
Key Employees 44
Locations And Subsidiaries 45
Head Office 45
Other Locations & Subsidiaries 45
Appendix 46
Methodology 46
About GlobalData 46
Contact Us 46
Disclaimer 46
List of Tables
The Broad Institute Inc, Pharmaceuticals & Healthcare, Key Facts 1
The Broad Institute Inc, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 6
The Broad Institute Inc, Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 7
The Broad Institute Inc, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 8
The Broad Institute Inc, Deals By Therapy Area, 2010 to YTD 2016 9
The Broad Institute Inc, Medical Devices Deals, 2010 to YTD 2016 10
The Broad Institute Inc, Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 11
Cohen Veterans Bioscience Partners with Stanley Center for Psychiatric Research 13
Broad Institute Genomic Services Partners with Takeda Pharma 14
Beryllium Enters into Development Agreement with Broad Institute for MCL-1 platform 15
Bayer HealthCare Expands Co-Development Agreement with Broad Institute for Cardiovascular Therapies 16
AstraZeneca Enters into Research Agreement with Broad Institute and Whitehead Institute 17
Eisai Enters into Research Agreement with Broad Institute 19
Tetra Discovery Enters Into Co-Development Agreement With Stanley Center For Schizophrenia Therapeutics 20
EMD Serono Enters Into Research Agreement With Pfizer And Broad Institute 21
Massachusetts General Hospital Enters Into Collaboration Agreement With Broad Institute And Amgen For Drug Discovery 23
Eisai Enters Into Co-Development Agreement With Broad Institute For Neglected Tropical Diseases And Tuberculosis 25
Bayer HealthCare Pharma And Broad Institute Enter Into Agreement To Develop Cancer Therapy 26
AstraZeneca And Broad Institute Partner To Advance Discovery Of Antibacterial And Antiviral Agents 28
Albany Molecular Research Enters into Licensing Agreement with Broad Institute 29
Evotec Enters into Licensing Agreement with Broad Institute 30
Transposagen Biopharma Enters into Licensing Agreement with Broad Institute 31
Neon Therapeutics Enters into Licensing Agreement with Broad Institute, Dana-Farber Cancer Institute and Massachusetts General Hospital 32
Sigma Life Science Enters into Licensing Agreement with Broad Institute for Crispr Gene Engineering System 34
GE Healthcare Life Sciences Enters into Licensing Agreement with Broad Institute for Crispr Gene Engineering System 35
Editas Medicine Enters into Licensing Agreement with Broad Institute of Harvard and MIT, and Harvard University 36
Clontech Lab Enters into Licensing Agreement with Broad Institute for Crispr Gene Editing System 38
Sage Labs Enters into Licensing Agreement with Broad Institute for Crispr Gene Editing System 39
Applied Stemcell Enters into licensing Agreement with Broad Institute 40
Horizon Discovery Enters into Licensing Agreement with Broad Institute for Crispr Gene Editing System 41
ChemAxon Enters Into Licensing Agreement With Broad Institute Of Harvard And MIT 42
The Broad Institute Inc, Key Competitors 43
The Broad Institute Inc, Key Employees 44
The Broad Institute Inc, Other Locations 45
The Broad Institute Inc, Subsidiaries 45
List of Figures
The Broad Institute Inc, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 1
The Broad Institute Inc, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 1
The Broad Institute Inc, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 1
The Broad Institute Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 1
The Broad Institute Inc, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 6
The Broad Institute Inc, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 7
The Broad Institute Inc, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 8
The Broad Institute Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 9
The Broad Institute Inc, Medical Devices Deals, 2010 to YTD 2016 10
